Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Amgen (NQ: AMGN ) 312.86 -18.06 (-5.46%) Streaming Delayed Price Updated: 4:00 PM EDT, Sep 25, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Amgen < Previous 1 2 3 4 5 Next > Eli Lilly’s Path to the Next Trillion Market Capitalization August 26, 2024 Eli Lilly and Co. (NYSE: LLY) is a pharmaceutical giant that's made headlines for its GLP-1/GIP weight loss drug Tirzepatide, aka Mounjaro, for Type 2 diabetes. Via MarketBeat MarketBeat Week in Review – 8/5 - 8/9 August 10, 2024 Stocks were looking for direction to end the week, but next week may bring more volatility with the latest reading on inflation and the start of retail earnings Via MarketBeat Topics Economy Exposures Economy Interest Rates Amgen's MariTide Weight Loss Potential: Stock Outlook August 07, 2024 Amgen's shares fell 2.4% after-hours trading due to a mixed earnings release. MariTide, the company's weight loss drug, is in Phase II FDA trials. Via MarketBeat Topics Intellectual Property Exposures Intellectual Property Product Safety Amgen Inc. (NASDAQ: AMGN) Records 52-Week High Tuesday Morning January 02, 2024 Via Investor Brand Network CPI Data Sparks Rally in Biotech Stocks July 15, 2024 Following lower-than-expected inflation data on Thursday, The biotech sector broke out above resistance, closing the week up 6%, far outperforming the market. Via MarketBeat Topics ETFs Economy Exposures Interest Rates Positive News is Driving This Cancer Drug Maker’s Stock Higher July 15, 2024 IDEAYA Biosciences stock is up more than 16% on positive treatment data in a Phase 2 clinical trial, but after a 76% run-up, IDYA stock may need a breather Via MarketBeat Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex July 02, 2024 The biotech sector (IBB) is trading just 3% away from its 52-week high and a significant resistance level, suggesting a potential breakout. Via MarketBeat Topics ETFs Exposures COVID-19 Biotechs Race to Develop New Treatments as Global Pancreatic Cancer Market Size Expected to Reach $7.5 Billion by 2033 June 20, 2024 EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:KYMR),(NASDAQ:GILD),(OTCQX:RHHBY),(NASDAQ:AMGN) EQNX::TICKER_END Via FinancialNewsMedia Biotechs Race to Develop New Treatments as Global Pancreatic Cancer Market Size Expected to Reach $7.5 Billion by 2033 June 20, 2024 From FN Media Group LLC Via GlobeNewswire Moderna Stock Soars on Cutting-Edge Personalized Cancer Vaccines June 17, 2024 Biotechnology firm Moderna Inc. (NASDAQ: MRNA) made mainstream headlines during the pandemic for its COVID-19 vaccines. Moderna is focused on messenger RNA Via MarketBeat Exposures COVID-19 Biotech Sector Nears Breakout: Will it Outperform in Q2? April 03, 2024 The Biotech sector ETF is consolidating in its upper range, indicating a potential sector breakout despite modest year-to-date gains Via MarketBeat Topics ETFs 7 Stocks That Will Drive the Weight Loss Drugs Market March 28, 2024 The booming weight loss drug market presents both lucrative potential and significant risks for investors seeking to capitalize on the global obesity crisis. Via MarketBeat 4 Oversold Large Cap Stocks Yielding High Dividends March 14, 2024 Overlooked, oversold large-cap stocks offer compelling dividend yields for investors seeking income and potential capital appreciation Via MarketBeat Topics Artificial Intelligence Economy Exposures Artificial Intelligence Interest Rates Amazon Stock: Why it's Finally Included in the Dow Index February 29, 2024 Amazon replaced Walgreens in the Dow. While a positive move for Amazon, any impact on the stock's price may be limited due to low index weighting. Via MarketBeat Topics Economy Stocks Exposures Economy US Equities Are these frigid Dow stocks in for a longer winter? February 08, 2024 These three Dow laggards have suffered double-digit percentage declines this winter, contributing to the Dow’s underperformance versus other major averages. Via MarketBeat Topics Economy Stocks Exposures Economy US Equities IBM, Verizon, Merck stocks lead Dow to new highs January 31, 2024 The Dow hits record highs with IBM, Verizon, Merck, and insurer Travelers leading the way; those strong stocks don't make much of a dent in S&P performance Via MarketBeat Topics Stocks Exposures US Equities 5 top healthcare stocks for earnings growth in 2024 January 25, 2024 2024 holds promise for healthcare stocks, with Humana, Elevance, and others expected to boost earnings, as analysts say many industry pressures have been removed. Via MarketBeat GLP-1: Beyond Diabetes, a Blockbuster Horizon Beckons January 10, 2024 Via Investor Brand Network GLP-1: Beyond Diabetes, a Blockbuster Horizon Beckons January 10, 2024 EQNX::TICKER_START (NASDAQ:LEXX),(NASDAQ:AMGN),(NYSE:LLY),(OTCQX:RHHBY),(NASDAQ:WW) EQNX::TICKER_END Via FinancialNewsMedia 3 health care stocks off to strong starts in 2024 January 10, 2024 With the bullish news flow lately, the market has taken a liking to health care stocks in recent weeks - including these three early 2024 gainers. Via MarketBeat Topics Artificial Intelligence Exposures Artificial Intelligence Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030 January 09, 2024 EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:AMGN),(NASDAQ:AMAM),(NASDAQ:ELEV),(NASDAQ:NKTX) EQNX::TICKER_END Via FinancialNewsMedia Will the Biotech sector sustain its momentum in 2024? January 04, 2024 The iShares Biotechnology ETF (NASDAQ: IBB) emerged as a standout star, closing the first day of the year with a solid upswing of nearly 4%. Via MarketBeat Topics ETFs 5 Dow stocks to track during the market correction November 01, 2023 The Dow Jones Industrial Average is struggling in correction territory, but savvy investors keep an eye on resilient stocks like Microsoft, Amgen, and Walmart. Via MarketBeat Topics ETFs Stocks Exposures US Equities Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030 January 09, 2024 From FN Media Group LLC Via GlobeNewswire Get Ready for Next Generation of Diabetes, Weight-Management Drugs November 01, 2023 Via Investor Brand Network Get Ready for Next Generation of Diabetes, Weight-Management Drugs November 01, 2023 EQNX::TICKER_START (NASDAQ:LEXX),(NYSE:JNJ),(NYSE:SNY),(NASDAQ:AMGN),(NYSE:NVS) EQNX::TICKER_END Via FinancialNewsMedia Investor patience tested as pharmaceutical stocks take a tumble November 01, 2023 The healthcare sector faces a selloff as pharmaceutical giants report lackluster earnings; even Amgen's strong results failed to prevent selling in the sector Via MarketBeat Global Cancer Vaccines Market Share Is Expected To Reach $19.27 Billion By 2030 October 25, 2023 EQNX::TICKER_START (OTCPK:DTCFF),(CSE:DTC),(NASDAQ:JAZZ),(NASDAQ:EXEL),(NASDAQ:AMGN),(NASDAQ:REGN) EQNX::TICKER_END Via FinancialNewsMedia Why These 3 Equal-Weighted ETFs Deserve a Portfolio Spot October 19, 2023 These three equally-weighted exchange traded funds that offer superior diversification and risk adjusted returns are worth a look. Via MarketBeat Topics ETFs Prescriptions for Portfolio Health: 3 Resilient Healthcare Stocks October 12, 2023 During the peak of the recent selloff, the healthcare sector outshone, with three stocks showing resilience and impressive upward moves. Via MarketBeat Topics ETFs < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.